EUVIMEDAtrasti EUVIMED
Open access · CC BY-NC 4.0

SARS‐CoV ‐2 main protease mutation analysis via a kinematic method

Xiyu Chen iD, Sigrid Leyendecker, Henry van den Bedem

Proteins: Structure, Function, and Bioinformatics · 2023

DOI: 10.1002/prot.26543 ↗

At a glance

Journal article in Proteins: Structure, Function, and Bioinformatics, 2023. Written by Xiyu Chen and 2 co-authors. Institution: Department of Mechanical Engineering, Institute of Applied Dynamics, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany. Major MEDLINE topics: SARS-CoV-2, Coronavirus 3C Proteases, Mutation. Cited 5 times so far (Crossref); 58 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: NIH HHS, Deutsche Forschungsgemeinschaft, National Institutes of Health.

SantraukaSubjectsBibliografiniai duomenysCiteRelated studies

Abstract (original language)

The Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS‐CoV‐2) is the virus responsible for the COVID‐19 pandemic. COVID‐19 continues to cause millions of deaths globally in part due to immune‐evading mutations. SARS‐CoV‐2 main protease (Mpro) is an important enzyme for viral replication and potentially an effective drug target. Mutations affect the dynamics of enzymes and thereby their activity and ability to bind ligands. Here, we use kinematic flexibility analysis (KFA) to identify how mutations and ligand binding changes the conformational flexibility of Mpro. KFA decomposes macromolecules into regions of different flexibility near‐instantly from a static structure, allowing conformational dynamics analysis at scale. Altogether, we analyzed 47 mutation sites across 69 Mpro–ligand complexes resulting in more than 3300 different structures which includes 69 mutated structures with all 47 sites mutated simultaneously and 3243 single residue mutated structures. We found that mutations generally increased the conformational flexibility of the protein. Understanding the impact of mutations on the flexibility of Mpro is essential for identifying potential drug targets in the treatment of SARS‐CoV‐2. Further studies in this area can offer valuable insights into the mechanisms of molecular recognition.

Subjects

MeSH terms (MEDLINE)

SARS-CoV-2Coronavirus 3C ProteasesMutationCOVID-19HumansMolecular Dynamics SimulationProtein ConformationBiomechanical PhenomenaBinding SitesProtein BindingLigands

Author keywords

SARS-CoV-2 Mprokinematic methodmutation analysis

Substances

Coronavirus 3C Proteases3C-like proteinase, SARS-CoV-2Ligands

Authors and institutions

  • Department of Mechanical Engineering, Institute of Applied Dynamics, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
  • Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, California, USA.

ORCID profiles: Xiyu Chen

Funding

  • NIH HHS
  • Deutsche Forschungsgemeinschaft
  • National Institutes of Health

Cite

APA

Chen, X., Leyendecker, S., & van den Bedem, H. (2023). SARS‐CoV ‐2 main protease mutation analysis via a kinematic method. Proteins: Structure, Function, and Bioinformatics. https://doi.org/10.1002/prot.26543

Vancouver

Chen X, Leyendecker S, van den Bedem H. SARS‐CoV ‐2 main protease mutation analysis via a kinematic method. Proteins: Structure, Function, and Bioinformatics. 2023. doi:10.1002/prot.26543

BibTeX
@article{Chen2023,
  author = {Chen, Xiyu and Leyendecker, Sigrid and van den Bedem, Henry},
  title = {SARS‐CoV ‐2 main protease mutation analysis via a kinematic method},
  journal = {Proteins: Structure, Function, and Bioinformatics},
  year = {2023},
  doi = {10.1002/prot.26543}
}
Start for free →